PITTSBURGH, Sept. 19, 2019 /PRNewswire/ -- PRESS RELEASE -- FARMACEUTICALRX, a therapeutics company focused on the medical marijuana sector with a multi-state operational platform, has announced that it has received full certification to operate its grower/processor operations in Pennsylvania. FARMACEUTICALRX was awarded a Grower/Processor license last summer from the Pennsylvania Medical Marijuana Office as part of Round Two of the Medical Marijuana Program. FARMACEUTICALRX's grower/processor facility, located in Farrell, Penn., is a state-of-the-art facility designed to develop high-quality medical marijuana products for patients in Pennsylvania. The company commenced harvesting in August and projects that it will commence medical product sales in Pennsylvania in the coming weeks.
"We are excited to be the first grower/processor to be fully certified to operate in Pennsylvania in Round 2," stated Rebecca Myers, founder and CEO of FARMACEUTICALRX. "Our living soil cultivation, extraction and high-quality focused product development platform is growing rapidly and Pennsylvania is a core component of our multi-state operations. We will differentiate ourselves in the market with our living soil style of cultivation, our development of high quality therapeutics that include our inhouse derived terpenes and with the development of our leading brands."
FARMACEUTICALRX is the first Phase II Grower/Processor to be fully certified to operate in Pennsylvania.
FARMACEUTICALRX is focused on advancing the knowledge base around medical marijuana therapies. The company's formulation and branding engine is powered by multiple R&D relationships with premier academic centers held by its sister company. FARMACEUTICALRX is committed to offering the highest-quality products to patients in the Pennsylvania market.
